Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
SARS-CoV-2 a novel coronavirus | DynaMed |

Mortality secondary to COVID-19 is highly variable and related to age, severity of disease, and comorbidities. Estimated mortality is

    0.3%-2.3% for all patients.
    10%-23% for hospitalized patients.
    26%-50% for patients admitted to the ICU.
    37%-88% for patients requiring invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO).

Related reading ...
Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 [Alpha] in the United States | NCBI - Feb. 2021 |

'Sapere aude'

by Oui (Oui) on Thu Dec 23rd, 2021 at 09:55:33 AM EST
[ Parent ]

Others have rated this comment as follows:


Occasional Series